F2RL1 and cancer: The activation of protease-activated receptor 2 (PAR2), located at the nerve endings of the nociceptors, has long been implicated in inflammatory, visceral pain, and cancer-evoked pain, whereas PAR1 evokes itch responses in the skin.6